Vaccine slashes risk of shingles in adults with MS in US, study finds

A new U.S. study has found that use of the recombinant zoster vaccine effectively reduces the risk of herpes zoster — more commonly known as shingles — in adults with multiple sclerosis (MS). Specifically, in a retrospective analysis involving more than 14,000 vaccinated people with MS, receiving the recombinant zoster vaccine cut the risk of […] The post Vaccine slashes risk of shingles in adults with MS in US, study finds appeared first on Multiple Sclerosis News Today.